The levels of HTRA1, a negative regulator of mesenchymal stem cell (MSC) adipogenesis, and matrix metalloproteinase-13 (MMP-13) proteins, which played an important role in the pathophysiology of adipose tissue, were evidently high in the visceral adipose tissue of IR obese patients and also in the cardiac tissue of DCM patients [38,39,40], lending support to HTRA1 mediating the potential pathogenesis of DCM and obesity. The gene discussed is HTRA1; the disease is obesity disorder.